Replies to post #720784 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

theorysuit,

The subcutaneous injection of checkpoint inhibitors is no shoe in. I think both Merck and BMY know this but BMY simply has no choice but to try with their padufa date while Merck is sitting pretty on the combo results. See any reason for Merck to strike first?; ). Best wishes.

[dstock07734]

You become delusional now.
When was the last time the PI of the combo trial Timothy Cloughesy had meetings with Merck? It was three years ago. Do you happen to think Merck lost interest in the combo trial?

Hope the following could jog your memory. Pay special attention to when the construction was started.

[learningcurve2020]

They don't have much left to dilute. Look for a reverse split with a new batch of authorized or perhaps they fold and private Advent "buys" NWBO's IP.


>>Dilution is going to be nonstop and the only certain thing that is going to happen.